Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Percheron Therapeutics ( (AU:PER) ) has shared an update.
Percheron Therapeutics Limited has announced a change in the director’s interest, with Director James Garner acquiring 7.5 million fully paid ordinary shares, increasing his total holding to 50 million shares. The acquisition was made through on-market purchases, reflecting a strategic move to strengthen his stake in the company, potentially signaling confidence in the company’s future prospects.
More about Percheron Therapeutics
Technical Sentiment Signal: Sell
Current Market Cap: $7.54M
See more insights into PER stock on TipRanks’ Stock Analysis page.